Northern Trust’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Sell |
1,154,314
-145,009
| -11% | -$396K | ﹤0.01% | 2744 |
|
|
2025
Q1 | $2.18M | Buy |
1,299,323
+110,977
| +9% | +$186K | ﹤0.01% | 2881 |
|
|
2024
Q4 | $1.94M | Buy |
1,188,346
+60,004
| +5% | +$97.8K | ﹤0.01% | 3045 |
|
|
2024
Q3 | $4.69M | Buy |
1,128,342
+273,770
| +32% | +$1.14M | ﹤0.01% | 2509 |
|
|
2024
Q2 | $4.67M | Sell |
854,572
-11,569
| -1% | -$63.2K | ﹤0.01% | 2442 |
|
|
2024
Q1 | $8.66M | Sell |
866,141
-20,832
| -2% | -$208K | ﹤0.01% | 2129 |
|
|
2023
Q4 | $3.62M | Buy |
886,973
+54,366
| +7% | +$222K | ﹤0.01% | 2684 |
|
|
2023
Q3 | $3.22M | Buy |
832,607
+16,908
| +2% | +$65.4K | ﹤0.01% | 2680 |
|
|
2023
Q2 | $4.86M | Buy |
815,699
+53,299
| +7% | +$318K | ﹤0.01% | 2519 |
|
|
2023
Q1 | $2.49M | Sell |
762,400
-18,246
| -2% | -$59.7K | ﹤0.01% | 2845 |
|
|
2022
Q4 | $3.08M | Sell |
780,646
-9,869
| -1% | -$39K | ﹤0.01% | 2764 |
|
|
2022
Q3 | $4.74M | Sell |
790,515
-3,160
| -0.4% | -$19K | ﹤0.01% | 2522 |
|
|
2022
Q2 | $5.1M | Buy |
793,675
+35,379
| +5% | +$227K | ﹤0.01% | 2496 |
|
|
2022
Q1 | $6.26M | Sell |
758,296
-35,891
| -5% | -$296K | ﹤0.01% | 2450 |
|
|
2021
Q4 | $12.3M | Buy |
794,187
+8,069
| +1% | +$125K | ﹤0.01% | 2092 |
|
|
2021
Q3 | $17.7M | Buy |
786,118
+494,789
| +170% | +$11.1M | ﹤0.01% | 1886 |
|
|
2021
Q2 | $5.73M | Buy |
291,329
+127,148
| +77% | +$2.5M | ﹤0.01% | 2760 |
|
|
2021
Q1 | $5.5M | Buy |
+164,181
| New | +$5.5M | ﹤0.01% | 2688 |
|